论文部分内容阅读
据美国和俄罗斯研究者报道，抗γ-干扰素（anthintederon－Y）抗体单用或与抗肿瘤坏死因子、（antLTNF－a）抗体合用的抗细胞因子疗法显然对类风湿性关节炎（RA）有效。在这一初步研究中，ZO例原先对至少4种标准的症状缓解性抗类风湿药物（DMARDS）无效的，或不能耐受或未接受
Anti-cytokine therapy in combination with anti-tumor necrosis factor and anti-tumor necrosis factor (antLTNF-a) antibodies has been shown to significantly reduce the risk of rheumatoid arthritis (RA) in the United States and Russia, according to researchers in the United States. effective. In this preliminary study, ZO patients were originally ineffective, or intolerant or unacceptable for at least 4 of the standard symptoms-relieving antirheumatic drugs (DMARDS)